Member since: 2020
Organization: Narayana Hrudayalaya Institute Of Cardiac Sciences
Application Area: Personalized treatments that target genetic changes
"The product is very useful especially in CRC patients and we are able to define personalized care in this subgroup. Only a small amount of the tissue is required and hence without hampering other test we can get it done."
The therascreen BRAF V600E RGQ PCR Kit is a qualitative in vitro diagnostic test for the detection of V600E mutations in the BRAF gene. The test analyzes DNA extracted from formalin-fixed, paraffin-embedded (FFPE) tumor tissue, taken from a patient with colorectal cancer (CRC). It is intended to aid clinicians in identifying metastatic colorectal cancer (mCRC) patients eligible for treatment with BRAFTOVI (encorafenib) in combination with cetuximab.